CEMIP promotes small cell lung cancer proliferation by activation of glutamine metabolism via FBXW7/c-Myc-dependent axis

CEMIP as a potential biomarker and therapeutic target for breast cancer patients

(2022) Jinqi Xue et al.   International Journal of Medical Sciences

CEMIP promotes extracellular matrix‐detached prostate cancer cell survival by inhibiting ferroptosis

(2022) Bing Liu et al.   CANCER SCIENCE

Toxicities of Immunotherapy for Small Cell Lung Cancer

(2021) Yang Fu et al.   Frontiers in Oncology

MiR-148a-3p targets CEMIP to suppress the genesis of gastric cancer cells

(2021) Ming Song et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Update 2021: Management of Small Cell Lung Cancer

(2021) Sara Tariq et al.   LUNG

CEMIP, a novel adaptor protein of OGT, promotes colorectal cancer metastasis through glutamine metabolic reprogramming via reciprocal regulation of β-catenin

(2021) Qingling Hua et al.   ONCOGENE

A novel metastatic promoter CEMIP and its downstream molecular targets and signaling pathway of cellular migration and invasion in SCLC cells based on proteome analysis

(2020) Li Li et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Her4 promotes cancer metabolic reprogramming via the c-Myc-dependent signaling axis

(2020) Jing Han et al.   CANCER LETTERS

LncRNA GLCC1 promotes colorectal carcinogenesis and glucose metabolism by stabilizing c-Myc

(2019) Jiayin Tang et al.   Nature Communications

The endosomal protein CEMIP links Wnt signaling to MEK1-ERK1/2 activation in Selumetinib-resistant intestinal organoids

(2018) Hong-Quan Duong et al.   CANCER RESEARCH

ASC amino acid transporter 2, defined by enzyme-mediated activation of radical sources, enhances malignancy of GD2-positive small-cell lung cancer

(2018) Nobutoshi Esaki et al.   CANCER SCIENCE

AMPK/GSK3β/β-catenin cascade–triggered overexpression of CEMIP promotes migration and invasion in anoikis-resistant prostate cancer cells by enhancing metabolic reprogramming

(2018) Peng Zhang et al.   FASEB JOURNAL

FBXW7 deletion contributes to lung tumor development and confers resistance to gefitinib therapy

(2018) Yi Xiao et al.   Molecular Oncology

FBXW7: a critical tumor suppressor of human cancers

(2018) Chien-Hung Yeh et al.   Molecular Cancer

KIAA1199 promotes metastasis of colorectal cancer cells via microtubule destabilization regulated by a PP2A/stathmin pathway

(2018) Lei Zhao et al.   ONCOGENE

KIAA1199 promotes invasion and migration in non-small-cell lung cancer (NSCLC) via PI3K-Akt mediated EMT

(2018) Zhiyuan Tang et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

Transformation from non-small-cell lung cancer to small-cell lung cancer: molecular drivers and cells of origin

(2015) Matthew G Oser et al.   LANCET ONCOLOGY

Comprehensive genomic profiles of small cell lung cancer

(2015) Julie George et al.   NATURE

NF-κB-induced KIAA1199 promotes survival through EGFR signalling

(2014) Kateryna Shostak et al.   Nature Communications

MYC Degradation

(2014) A. S. Farrell et al.   Cold Spring Harbor Perspectives in Medicine

Unraveling the Role of KIAA1199, a Novel Endoplasmic Reticulum Protein, in Cancer Cell Migration

(2013) Nikki A. Evensen et al.   JNCI-Journal of the National Cancer Institute

Myc protein is stabilized by suppression of a novel E3 ligase complex in cancer cells

(2010) S. H. Choi et al.   GENES & DEVELOPMENT

Loss of FBXW7, a cell cycle regulating gene, in colorectal cancer: Clinical significance

(2009) Masaaki Iwatsuki et al.   INTERNATIONAL JOURNAL OF CANCER